By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verastem, Inc. 

215 First Street
Suite 440
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-858-0338 Fax: n/a


Company News
Verastem (VSTM) Reports Third Quarter 2015 Financial And Corporate Results 11/9/2015 11:48:55 AM
Verastem (VSTM) To Present Preclinical Data At SITC 2015 11/4/2015 11:36:03 AM
Verastem (VSTM) To Present Preclinical Data At The 2015 EORTC-National Cancer Institute-AACR International Conference On Molecular Targets And Cancer Therapeutics 10/27/2015 1:09:51 PM
Verastem (VSTM) Slashes Half Its Workforce After Cancer Drug Fails in Mid-Stage Trial 10/8/2015 3:38:01 PM
Verastem (VSTM) Stops Study of Experimental Cancer Therapy; Stock Plunges 9/28/2015 7:12:56 AM
Verastem (VSTM) Announces New Research Published In The Journal Cell That Highlights The Potential Of FAK Inhibition To Enhance The Efficacy Of Anti-Tumor Immunotherapy 9/25/2015 10:23:01 AM
Verastem (VSTM) To Present Preclinical Data At ESMO/ECCO 2015 9/17/2015 1:26:37 PM
Verastem (VSTM) To Present At Rodman & Renshaw 17th Annual Global Investment Conference 9/4/2015 7:34:18 AM
Verastem (VSTM) Issues Statement Regarding WCLC Presentations 8/27/2015 8:46:59 AM
In Response to Twitter Rumors and Phase II Data, Verastem (VSTM) Stock Plunges 8/27/2015 6:00:03 AM